XIST and central nervous system cancer: In this study, we demonstrated that XIST was upregulated in glioma tissues compared with NBTs, and XIST expression was elevated along with the pathological grade, while miR-204-5p expression was significantly decreased in glioma tissues compared with NBTs, and the expression level was negatively correlated with XIST expression.